Seattle Genetics & Dr. Clay Siegall: The Ultimate Duo in Cancer Research

Cancer is one of the most deadly diseases in history. Millions of people have lost their lives fighting this illness, and many people have had their limbs amputated in the process. Cancer can manifest from just about any organ in the human body such as the lungs, the brain, the liver or the prostate. With newer and better treatment options available, the mortality rate has drastically decreased in recent years, but the fight is far from over. This is where Dr. Clay Siegall comes into the frame, and he has played a key role in eradicating cancer. Dr. Siegall has a broad educational-base thanks to his degrees in Zoology and in Genetics.

Dr. Siegall is the founder of Seattle Genetics, and he has built this company from the ground-up. Seattle Genetics has been around for 20 years, and it has grown in a substantial way. In the early days, the company was made-up of only a small crew of individuals, but as of today, the company has nearly 900 employees. Seattle Genetics generates large amounts of capital on an annual basis. As of today, the company has a market value of over $10 billion. That’s right! The company earns revenue through a variety of ways such as from production partnerships, from the selling of its very own proprietary drugs and from the licensing of its technologies. Dr. Siegall has even helped to bring in extra billions of dollars from private fundraising.

What more can you say about this phenomenal man? What more can you say about Seattle Genetics? This dynamic duo has certainly rewritten the books on how to effectively fight cancer, but the duo’s work isn’t completely done. As long as cancer is around, Dr. Clay Siegall will be on the frontline of this valiant battle.